PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) AND SAFETY OF ARTESUNATE (AS) AND DIHYDROARTEMISININ (DHA) FOLLOWING A SINGLE ORAL DOSE OF ARTESUNATE DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY

被引：0
|
作者：
Onyamboko, Marie A. [1 ]
Atibu, Jef [1 ]
Lokomba, Vicky [1 ]
Meshnick, Steven [2 ]
Douoguih, Macaya [3 ]
Hemingway-Foday, Jennifer [4 ]
Koch, Matthew [4 ]
Wesche, David [5 ]
Capparelli, Edmund [6 ]
Fleckenstein, Larry [7 ]
Ryder, Robert [6 ]
Bose, Carl [2 ]
Wright, Linda [8 ]
Tshefu, Antoinette [1 ]
机构：
[1] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO
[2] Univ N Carolina, Chapel Hill, NC USA
[3] Aeras Global TB Vaccine Fdn, Rockville, MD USA
[4] RTI Int, Res Triangle Pk, NC USA
[5] Lundbeck Inc, Deerfield, IL USA
[6] Univ Calif San Diego, San Diego, CA 92103 USA
[7] Univ Iowa, Iowa City, IA USA
[8] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2009年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
224
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour
    Stibbe, Krista J. M.
    de Weerd, Sabina
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 286 (03) : 795 - 796
  • [32] Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour
    Krista J. M. Stibbe
    Sabina de Weerd
    Archives of Gynecology and Obstetrics, 2012, 286 : 795 - 796
  • [33] Electrocradiographic QRS Axis, Q Wave and T-wave Changes in 2nd and 3rd Trimester of Normal Pregnancy
    Sunitha, M.
    Chandrasekharappa, S.
    Brid, S. V.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (09) : BC17 - BC21
  • [34] PAIRED MEASUREMENTS OF TOTAL AND UNCONJUGATED ESTRIOL IN MATERNAL PLASMA DURING THE 2ND AND 3RD TRIMESTER OF PREGNANCY - THEIR RELATIONSHIP TO INTRAUTERINE GROWTH-RETARDATION
    BACIGALUPO, G
    SALING, EZ
    GESCHE, J
    JOURNAL OF PERINATAL MEDICINE, 1982, 10 (02) : 73 - 84
  • [35] Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment?
    Nahid Sarahian
    Marzieh Saei Ghare Naz
    Fahimeh Ramezani Tehrani
    Endocrine, 2021, 72 : 356 - 357
  • [36] Following SARS-CoV-2 in the first trimester of pregnancy, what should we do in the 2nd, 3rd trimesters, and postpartum in terms of thyroid assessment?
    Sarahian, Nahid
    Saei Ghare Naz, Marzieh
    Ramezani Tehrani, Fahimeh
    ENDOCRINE, 2021, 72 (02) : 356 - 357
  • [37] Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
    Katarina Dathe
    Johanna Frank
    Stephanie Padberg
    Stefanie Hultzsch
    Evelin Beck
    Christof Schaefer
    BMC Pregnancy and Childbirth, 22
  • [38] Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohort
    Dathe, Katarina
    Frank, Johanna
    Padberg, Stephanie
    Hultzsch, Stefanie
    Beck, Evelin
    Schaefer, Christof
    BMC PREGNANCY AND CHILDBIRTH, 2022, 22 (01)
  • [39] Three-dimensional ultrasonographic assessment of the umbilical cord during the 2nd and 3rd trimesters of pregnancy
    Hata, T
    Aoki, S
    Hata, K
    Miyazaki, K
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1998, 45 (03) : 159 - 164
  • [40] Utilization of hydroxyprogesterone during the 2nd or/and 3rd trimester among pregnancies with live birth deliveries in the sentinel distributed databases
    Tsai, Huei-Ting
    Shinde, Mayura
    Cosgrove, Austin
    Li, Jie
    Chang, Christina
    Nguyen, Christine P.
    Woods, Corinne M.
    Kolonoski, Joy
    Woodworth, Tiffany Siu
    Moeny, David
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 194 - 195
12345